Gene · 1489
CTF1: cardiotrophin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CTF1: cardiotrophin 1. Genes, record 1489. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1489
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16619 | Cardiotrophin-1 | 201 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents68
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025169942 A | 2025-11-14 | 886 | Q16619 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 11970 | Q16619 | Espacenet |
| JP 2025503989 A | 2025-02-06 | 131 | Q16619 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 11970 | Q16619 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 114941 | Q16619 | Espacenet |
| US 10772975 B2 | 2020-09-15 | 886 | Q16619 | Espacenet |
| JP 2019030327 A | 2019-02-28 | 21016 | Q16619 | Espacenet |
| US 9814760 B2 | 2017-11-14 | 886 | Q16619 | Espacenet |
| JP 2017121244 A | 2017-07-13 | 21016 | Q16619 | Espacenet |
| EP 3067422 A2 | 2016-09-14 | 1 | Q16619 | Espacenet |
1 to 10 of 68
See all 68 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,016
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CTF1 papers | Newest fiscal year |
|---|---|---|---|
| P20GM103408 | Idaho INBRE Program | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| R01HL076246 | Chemokines in healing myocardial infarction | 4 | 2025 |
| R01HL085440 | Resolution of inflammation in healing myocardial infarcts | 4 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 3 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 3 | 2025 |
| R01AI051321 | Structure-based engineering of immune cytokine signaling | 3 | 2025 |
| T32CA059366 | Cancer Biology Training Grant | 3 | 2025 |
| IK6BX004016 | BLRD Research Career Scientist Award Application | 2 | 2025 |
1 to 10 of 1,016Source NIH's project files
See all 1,016 nih grantsPapers1,601
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Before we redraw the line: Caution on steatosis-adjusted cT1 cut-offs for predicting mortality. | JHEP Rep | 2026 | 42785435 | PubTator, text mining | PubMed |
| Characterisation of liver disease using quantitative MRI: report of the imaging arm of the ELEGANCE study. | BMC Gastroenterol | 2026 | 42754838 | PubTator, text mining | PubMed |
| Brave New Frameworks: Synthesis and Structural Properties of Novel Covalent Triazine Frameworks From Commercial Dicyanobenzenes for Photocatalytic Applications. | Chempluschem | 2026 | 42473283 | PubTator, text mining | PubMed |
| Integrated multi-omics strategies for identifying novel therapies in psoriasis. | Bioinformatics | 2026 | 42209436 | PubTator, text mining | PubMed |
| FAD mutations suppress brain angiogenesis and neuroprotection by reducing γ-secretase processing and dimerization of VEGFR2. | bioRxiv | 2026 | 42182402 | PubTator, text mining | PubMed |
| Beyond resorption-driven coupling: a multi-layered framework for osteoclast-osteoblast communication and its therapeutic consequences. | Front Endocrinol (Lausanne) | 2026 | 42087879 | PubTator, text mining | PubMed |
| Elevated serum cardiotrophin-1 and interleukin-17 levels in psoriasis. | Ir J Med Sci | 2026 | 41979794 | PubTator, text mining | PubMed |
| Cardiotrophin-1 as a mediator between systolic blood pressure and left ventricular hypertrophy in obesity. | J Hypertens | 2026 | 41885341 | PubTator, text mining | PubMed |
| Substituent-induced oxidation-reduction molecular organic junction for interfacial hydrogen peroxide photosynthesis. | Nat Commun | 2026 | 41882021 | PubTator, text mining | PubMed |
| Clonal dynamics of HIV-infected and uninfected T cells. | EBioMedicine | 2026 | 41855971 | PubTator, text mining | PubMed |
1 to 10 of 1,601
See all 1,601 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1489
GET https://conductscience.org/api/genes/v1/1489/patents?page=2